| Literature DB >> 29895649 |
Alexander Joeris1, Christian Knoll1, Vasiliki Kalampoki1, Andrea Blumenthal1, George Gaskell2.
Abstract
OBJECTIVE: To gain information about the advantages/disadvantages of an implementation of patient-reported outcome measures (PROM) into the clinical routine of trauma/orthopaedic surgeons, and to identify the technical constraints confronting a successful implementation of PROMs.Entities:
Keywords: adult orthopaedics; public health
Mesh:
Year: 2018 PMID: 29895649 PMCID: PMC6009470 DOI: 10.1136/bmjopen-2017-020629
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Summary of demographics and working experience of participating surgeons
| Variable | n=1212 |
| Gender, n (%) | 1212 |
| Female | 126 (10.4) |
| Male | 1086 (89.6) |
| Age, n (%) | 1212 |
| 18–24 | 1 (0.1) |
| 25–34 | 256 (21.1) |
| 35–44 | 468 (38.6) |
| 45–54 | 307 (25.3) |
| 55–64 | 149 (12.3) |
| 65–74 | 26 (2.1) |
| 75 or older | 5 (0.4) |
| AO Region, n (%) | 1212 |
| Africa | 41 (3.4) |
| Asia-Pacific | 299 (24.7) |
| Europe | 394 (32.5) |
| Latin America | 217 (17.9) |
| Middle East | 133 (11.0) |
| North America | 128 (10.6) |
| Specialisation, n (%) | 1212 |
| Orthopaedics | 328 (27.1) |
| Trauma | 329 (27.1) |
| Craniomaxillofacial | 338 (27.9) |
| Spine | 201 (16.6) |
| Other | 16 (1.3) |
| Current position, n (%) | 1212 |
| Registrar | 249 (20.5) |
| Consultant | 611 (50.4) |
| Senior management/professorship | 335 (27.6) |
| Other | 17 (1.4) |
| Clinical experience, n (%) | 1212 |
| 0–4 years | 183 (15.1) |
| 5–9 years | 259 (21.4) |
| 10–14 years | 261 (21.5) |
| 15–19 years | 176 (14.5) |
| ≥20 years | 333 (27.5) |
| Workplace, n (%) | 1212 |
| University hospital | 457 (37.7) |
| Private hospital | 172 (14.2) |
| Public hospital | 337 (27.8) |
| Private practice | 62 (5.1) |
| Both university and non-university hospitals | 169 (13.9) |
| Other | 15 (1.2) |
Senior management/professorship includes the following positions: head, deputy head, assistant professor, and professor.
Univariable analysis evaluating the familiarity, and current use of PROMs in clinical routine and/or clinical research, according to geographical region, surgical specialty, current position, clinical experience and workplace
| Variable | n | Familiarity with disease-specific PROMs* | Familiarity with generic PROMs† | Current use of PROMs‡ | ||||||
| Yes | No | P values | Yes | No | P values | Yes | No | P values | ||
| AO Region | ||||||||||
| Africa | 41 | 25 (61.0) | 16 (39.0) | <0.001 | 20 (48.8) | 21 (51.2) | <0.001 | 10 (24.4) | 31 (75.6) | 0.004 |
| Asia-Pacific | 299 | 126 (42.1) | 173 (57.9) | 95 (31.8) | 204 (68.2) | 72 (24.2) | 225 (75.8) | |||
| Europe | 394 | 270 (68.5) | 124 (31.5) | 238 (60.4) | 156 (39.6) | 128 (32.5) | 266 (67.5) | |||
| Latin America | 217 | 97 (44.7) | 120 (55.3) | 76 (35.0) | 141 (65.0) | 54 (24.9) | 163 (75.1) | |||
| Middle East | 133 | 50 (37.6) | 83 (62.4) | 33 (24.8) | 100 (75.2) | 21 (15.8) | 112 (84.2) | |||
| North America | 128 | 93 (72.7) | 35 (27.3) | 85 (66.4) | 43 (33.6) | 40 (31.3) | 88 (68.8) | |||
| Surgical specialty | ||||||||||
| Orthopaedics | 328 | 240 (73.2) | 88 (26.8) | <0.001 | 162 (49.4) | 166 (50.6) | <0.001 | 107 (32.6) | 221 (67.4) | <0.001 |
| Trauma | 329 | 197 (59.9) | 132 (40.1) | 142 (43.2) | 187 (56.8) | 70 (21.3) | 258 (78.7) | |||
| Craniomaxillofacial | 338 | 46 (13.6) | 292 (86.4) | 107 (31.7) | 231 (68.3) | 52 (15.4) | 285 (84.6) | |||
| Spine | 201 | 172 (85.6) | 29 (14.4) | 128 (63.7) | 73 (36.3) | 91 (45.3) | 110 (54.7) | |||
| Current position | ||||||||||
| Registrar | 249 | 116 (46.6) | 133 (53.4) | 0.013 | 80 (32.1) | 169 (67.9) | <0.001 | 63 (25.3) | 186 (74.7) | 0.665 |
| Consultant | 611 | 352 (57.6) | 259 (42.4) | 296 (48.4) | 315 (51.6) | 171 (28.1) | 438 (71.9) | |||
| Senior management/professorship | 335 | 184 (54.9) | 151 (45.1) | 164 (49.0) | 171 (51.0) | 88 (26.3) | 247 (73.7) | |||
| Clinical experience (years) | ||||||||||
| 0–4 | 183 | 75 (41.0) | 108 (59.0) | 0.001 | 59 (32.2) | 124 (67.8) | <0.001 | 31 (16.9) | 152 (83.1) | 0.024 |
| 5–9 | 259 | 139 (53.7) | 120 (46.3) | 107 (41.3) | 152 (58.7) | 72 (27.8) | 187 (72.2) | |||
| 10–14 | 261 | 143 (54.8) | 118 (45.2) | 116 (44.4) | 145 (55.6) | 76 (29.2) | 184 (70.8) | |||
| 15–19 | 176 | 102 (58.0) | 74 (42.0) | 89 (50.6) | 87 (49.4) | 48 (27.3) | 128 (72.7) | |||
| ≥20 | 333 | 202 (60.7) | 131 (39.3) | 176 (52.9) | 157 (47.1) | 98 (29.5) | 234 (70.5) | |||
| Workplace | ||||||||||
| University hospital | 457 | 284 (62.1) | 173 (37.9) | 0.001 | 253 (55.4) | 204 (44.6) | <0.001 | 120 (26.3) | 336 (73.7) | 0.899 |
| Private hospital | 172 | 85 (49.4) | 87 (50.6) | 65 (37.8) | 107 (62.2) | 43 (25.0) | 129 (75.0) | |||
| Public hospital | 337 | 165 (49.0) | 172 (51.0) | 121 (35.9) | 216 (64.1) | 92 (27.3) | 245 (72.7) | |||
| Private practice | 62 | 31 (50.0) | 31 (50.0) | 20 (32.3) | 42 (67.7) | 15 (24.2) | 47 (75.8) | |||
| University and non-university hospitals | 169 | 88 (52.1) | 81 (47.9) | 81 (47.9) | 88 (52.1) | 49 (29.2) | 119 (70.8) | |||
P values derived from Χ2 test.
Due to extremely low frequencies, the categories ‘Other’ of surgical specialty, current position and workplace have been excluded from the current tabulation and comparison.
*For example, Oxford Knee Score, Oswestry Disability Index.
†For example, EuroQol-5D (EQ-5D) or 36-Item Short Form Health Survey (SF-36).
‡This variable derived after reclassifying ‘Current use of PROMs in your daily clinical work’ (No, I do not use PROMs/Yes for research purposes only vs the remaining three categories).
PROM, patient-reported outcome measure.
Multivariable logistic regression analyses evaluating the effect of AO Region, specialisation, current position, clinical experience, and workplace on the familiarity with generic PROMs, the familiarity with disease-specific PROMs and the current use of PROMs
| Variable | Category | Familiarity with disease-specific PROMs | Familiarity with generic PROMs | Current use of PROMs | ||||||
| OR | 95% CI | P values | OR | 95% CI | P values | OR | 95% CI | P values | ||
| AO Region | Europe | 1.00 | 1.00 | 1.00 | ||||||
| Africa | 1.12 | (0.45 to 2.81) | 0.805 | 0.58 | (0.29 to 1.17) | 0.126 | 0.46 | (0.22 to 0.95) | 0.036 | |
| Asia-Pacific | 0.35 | (0.23 to 0.53) | <0.001 | 0.31 | (0.22 to 0.45) | <0.001 | 0.66 | (0.47 to 0.93) | 0.017 | |
| Latin America | 0.39 | (0.25 to 0.61) | <0.001 | 0.42 | (0.29 to 0.63) | <0.001 | 0.48 | (0.32 to 0.71) | <0.001 | |
| Middle East | 0.23 | (0.14 to 0.38) | <0.001 | 0.22 | (0.13 to 0.35) | <0.001 | 0.36 | (0.23 to 0.57) | <0.001 | |
| North America | 1.60 | (0.89 to 2.86) | 0.113 | 1.23 | (0.78 to 1.94) | 0.378 | 0.77 | (0.49 to 1.20) | 0.254 | |
| Specialisation | Craniomaxillofacial | 1.00 | 1.00 | 1.00 | ||||||
| Orthopaedics | 23.7 | (15.18 to 37.00) | <0.001 | 2.17 | (1.53 to 3.07) | <0.001 | 3.41 | (2.42 to 4.80) | <0.001 | |
| Trauma | 11.62 | (7.57 to 17.85) | <0.001 | 1.45 | (1.02 to 2.06) | 0.039 | 1.91 | (1.35 to 2.70) | <0.001 | |
| Spine | 53.66 | (30.76 to 93.62) | <0.001 | 3.92 | (2.62 to 5.87) | <0.001 | 6.96 | (4.60 to 10.53) | <0.001 | |
| Current position | Registrar | 1.00 | 1.00 | 1.00 | ||||||
| Consultant | 1.39 | (0.93 to 2.08) | 0.106 | 1.68 | (1.16 to 2.42) | 0.006 | 1.15 | (0.81 to 1.64) | 0.427 | |
| Senior management/professorship | 1.52 | (0.93 to 2.47) | 0.096 | 1.76 | (1.14 to 2.72) | 0.011 | 1.36 | (0.89 to 2.07) | 0.156 | |
| Clinical experience (years) | ≥20 | 1.00 | 1.00 | 1.00 | ||||||
| 0–4 | 0.67 | (0.39 to 1.15) | 0.142 | 0.68 | (0.42 to 1.09) | 0.108 | 1.04 | (0.66 to 1.66) | 0.861 | |
| 5–9 | 1.04 | (0.66 to 1.66) | 0.859 | 0.87 | (0.59 to 1.30) | 0.498 | 1.12 | (0.75 to 1.66) | 0.578 | |
| 10–14 | 0.91 | (0.59 to 1.42) | 0.686 | 0.84 | (0.57 to 1.22) | 0.356 | 1.06 | (0.73 to 1.55) | 0.743 | |
| 15–19 | 1.11 | (0.68 to 1.80) | 0.672 | 1.00 | (0.66 to 1.50) | 0.994 | 1.03 | (0.69 to 1.55) | 0.882 | |
| Workplace | University hospital | 1.00 | 1.00 | 1.00 | ||||||
| Private hospital | 0.58 | (0.36 to 0.92) | 0.021 | 0.62 | (0.41 to 0.93) | 0.021 | 0.53 | (0.36 to 0.80) | 0.002 | |
| Public hospital | 0.48 | (0.33 to 0.70) | <0.001 | 0.48 | (0.35 to 0.66) | <0.001 | 0.48 | (0.35 to 0.66) | <0.001 | |
| Private practice | 0.66 | (0.31 to 1.41) | 0.283 | 0.35 | (0.18 to 0.69) | 0.002 | 0.30 | (0.16 to 0.59) | <0.001 | |
| Both university and non-university hospitals | 0.88 | (0.54 to 1.43) | 0.615 | 0.93 | (0.62 to 1.39) | 0.731 | 0.82 | (0.55 to 1.22) | 0.323 | |
Due to low frequencies, those classified as ‘Other’ in specialisation, current position or workplace, have been excluded from the current model.
PROM, patient-reported outcome measure.
Detailed reasons for and against collecting PROMs in clinical routine, provided by surgeons
| Subgroup | Variable | n | Strongly agree | Agree | Neither agree nor disagree | Disagree | Strongly disagree |
| Pro-PROMs* | PROMs can help prioritise clinical problems, n (%) | 292 | 66 (22.6) | 183 (62.7) | 30 (10.3) | 11 (3.8) | 2 (0.7) |
| PROMs can help facilitate communication between the doctor and the patient, n (%) | 291 | 71 (24.4) | 171 (58.8) | 38 (13.1) | 10 (3.4) | 1 (0.3) | |
| PROMs can screen for potential patient problem, n (%) | 287 | 63 (22.0) | 172 (59.9) | 43 (15.0) | 9 (3.1) | 0 (0.0) | |
| PROMs can identify patient’s preferences, n (%) | 291 | 50 (17.2) | 146 (50.2) | 74 (25.4) | 19 (6.5) | 2 (0.7) | |
| PROMs monitor changes/responses to treatment, n (%) | 291 | 96 (33.0) | 153 (52.6) | 35 (12.0) | 7 (2.4) | 0 (0.0) | |
| PROMs monitor and assess the general healthcare status of patients and potential changes, n (%) | 291 | 62 (21.3) | 173 (59.5) | 46 (15.8) | 10 (3.4) | 0 (0.0) | |
| PROMs can be helpful but are not substitutes to measure the clinical outcomes of patients, n (%) | 290 | 79 (27.2) | 145 (50.0) | 45 (15.5) | 18 (6.2) | 3 (1.0) | |
| PROMs help to monitor the quality of healthcare provision, n (%) | 290 | 52 (17.9) | 152 (52.4) | 70 (24.1) | 13 (4.5) | 3 (1.0) | |
| PROMs are useful for national/international comparison and benchmarking, n (%) | 290 | 79 (27.2) | 148 (51.0) | 51 (17.6) | 12 (4.1) | 0 (0.0) | |
| I am required to document patient-reported quality of life data by the government, regulatory bodies or for insurance reasons, n (%) | 291 | 24 (8.2) | 76 (26.1) | 66 (22.7) | 80 (27.5) | 45 (15.5) | |
| Contra-PROMs† | I do not believe in the usefulness of quality of life measurements in orthopaedics and traumatology, n (%) | 756 | 24 (3.2) | 74 (9.8) | 144 (19.0) | 304 (40.2) | 210 (27.8) |
| I do not have sufficient information, knowledge or experience to use PROMs in daily clinical routine, n (%) | 768 | 156 (20.3) | 319 (41.5) | 103 (13.4) | 145 (18.9) | 45 (5.9) | |
| It is too costly to implement PROMs in my daily clinical routine, n (%) | 759 | 40 (5.3) | 155 (20.4) | 326 (43.0) | 189 (24.9) | 49 (6.5) | |
| It is too time consuming to implement PROMs in my daily clinical routine, n (%) | 756 | 94 (12.4) | 264 (34.9) | 229 (30.3) | 139 (18.4) | 30 (4.0) | |
| The resistance of my patients to fill out patient-reported outcomes routinely is too high, n (%) | 751 | 35 (4.7) | 196 (26.1) | 317 (42.2) | 165 (22.0) | 38 (5.1) | |
| I am interested in using PROMs but I have not yet had the possibility to do so, n (%) | 761 | 200 (26.3) | 337 (44.3) | 136 (17.9) | 66 (8.7) | 22 (2.9) | |
| Resistance to PROMs within my hospital/department, n (%) | 752 | 39 (5.2) | 101 (13.4) | 315 (41.9) | 211 (28.1) | 86 (11.4) |
*Only participants who use PROMs (regularly in daily clinical work/infrequently in daily clinical work/both in daily clinical work and research) have been asked to provide reasons.
†Only participants who either do not use PROMs or use PROMs only for research purposes have been asked to provide reasons.
PROM, patient-reported outcome measure.
Figure 1Scree plot showing the variance in the data (eigenvalues) of the explorative factor analysis for surgeons who used patient-reported outcome measures (PROM) in their daily routine. The line until factor 4 shows the four of 10 components with an eigenvalue >1 which were included in the explorative factor analysis. The first four factors accounted for 66% of the total cumulative variance.
Figure 2Factor analysis path diagram displaying the variance of agreement/disagreement for each statement (why patient-reported outcome measures (PROM) are used in clinical routine) explained by the different factors. Factor 1: quality of care, factor 2: measurement of outcomes, factor 3: regulations, factor 4: limitations of PROMs.
Aspects considered important for an implementation of PROM-collecting instruments into the daily clinical routine
| Variable | n=1212 |
| User-friendliness (for hospital staff and patients), n (%) | 986 |
| Very important | 605 (61.4) |
| Important | 333 (33.8) |
| Neither important nor unimportant | 42 (4.3) |
| Unimportant | 4 (0.4) |
| Very unimportant | 2 (0.2) |
| Costs (acquisition and maintenance), n (%) | 985 |
| Very important | 389 (39.5) |
| Important | 459 (46.6) |
| Neither important nor unimportant | 115 (11.7) |
| Unimportant | 20 (2.0) |
| Very unimportant | 2 (0.2) |
| Time efficiency, n (%) | 976 |
| Very important | 543 (55.6) |
| Important | 370 (37.9) |
| Neither important nor unimportant | 56 (5.7) |
| Unimportant | 4 (0.4) |
| Very unimportant | 3 (0.3) |
| Compatibility to existing software tools in my hospital (eg, electronic medical records), n (%) | 984 |
| Very important | 449 (45.6) |
| Important | 400 (40.7) |
| Neither important nor unimportant | 110 (11.2) |
| Unimportant | 20 (2.0) |
| Very unimportant | 5 (0.5) |
| Interpretation and clinical relevance of results, n (%) | 986 |
| Very important | 529 (53.7) |
| Important | 404 (41.0) |
| Neither important nor unimportant | 47 (4.8) |
| Unimportant | 4 (0.4) |
| Very unimportant | 2 (0.2) |
PROM, patient-reported outcome measure.